CN204563307U - The treatment of release type potential balance is pasted - Google Patents
The treatment of release type potential balance is pasted Download PDFInfo
- Publication number
- CN204563307U CN204563307U CN201520234215.XU CN201520234215U CN204563307U CN 204563307 U CN204563307 U CN 204563307U CN 201520234215 U CN201520234215 U CN 201520234215U CN 204563307 U CN204563307 U CN 204563307U
- Authority
- CN
- China
- Prior art keywords
- treatment
- release type
- type potential
- potential balance
- conductive electrodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010020772 Hypertension Diseases 0.000 claims abstract description 11
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 11
- 208000004930 Fatty Liver Diseases 0.000 claims abstract description 10
- 206010019708 Hepatic steatosis Diseases 0.000 claims abstract description 10
- 208000010706 fatty liver disease Diseases 0.000 claims abstract description 10
- 231100000240 steatosis hepatitis Toxicity 0.000 claims abstract description 10
- 208000019622 heart disease Diseases 0.000 claims abstract description 9
- 239000013536 elastomeric material Substances 0.000 claims abstract description 5
- 239000010410 layer Substances 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 20
- 229920000049 Carbon (fiber) Polymers 0.000 claims description 9
- 239000004917 carbon fiber Substances 0.000 claims description 9
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 239000012790 adhesive layer Substances 0.000 claims description 4
- 239000004020 conductor Substances 0.000 claims description 4
- 229910002804 graphite Inorganic materials 0.000 claims description 3
- 239000010439 graphite Substances 0.000 claims description 3
- 229910052755 nonmetal Inorganic materials 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 22
- 201000010099 disease Diseases 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 16
- 208000006820 Arthralgia Diseases 0.000 abstract description 3
- 238000009098 adjuvant therapy Methods 0.000 abstract description 3
- 238000001467 acupuncture Methods 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 206010020880 Hypertrophy Diseases 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000005030 aluminium foil Substances 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000035487 diastolic blood pressure Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010059245 Angiopathy Diseases 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 206010046555 Urinary retention Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 238000001465 metallisation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 208000022530 polyphagia Diseases 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000002889 sympathetic effect Effects 0.000 description 2
- 210000000331 sympathetic ganglia Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010006298 Breast pain Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000011104 metalized film Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Electrotherapy Devices (AREA)
Abstract
This utility model relates to a kind of auxiliary medical apparatus, and namely the treatment of release type potential balance is pasted.Release type potential balance treats the purposes be attached in hypertension, heart disease, diabetes, cyclomastopathy, prostatosis, fatty liver, arthralgia, rheumatalgia auxiliary treatment; Described release type potential balance treatment subsides comprise at least two conductive electrodes, contact resistance elastomeric material layer between two conductive electrodes, form current loop.Paste use through Disease, property subsides once a day can take effect for 6-8 hour for three days on end afterwards, use more than 2 weeks, successful, and the auxiliary treatment being conducive to Disease pastes use.To diseases such as hypertension, heart disease, diabetes, cyclomastopathy, prostatosis, fatty liver, arthralgia, rheumatalgia, there is obvious adjuvant treatment effect.
Description
technical field
This utility model relates to a kind of auxiliary medical apparatus, and namely the treatment of release type potential balance is pasted.
Background technology
In the prior art, mechanism and utility model point: tradition " theory of Chinese medical science " " dialectical theory of TCM Zang-fu " confirms, 361 acupuncture points of human body on 14 primary meridians, are associated with internal organs of the body by meridians, are again the position points that organ disease reacts on body surface simultaneously.Find in the large quantity research at modern times China and foreign countries' meridians and acupuncture point, acupuncture point distinctively on human body has bioactive point, the state of human internal organs by the transmission of meridians, in the characteristic of final body present acupuncture point.Acupuncture point point, compared with the region, non-acupuncture point of its periphery, obviously has different electrical characteristics, has the characteristics such as high potential, Low ESR, high capacitance.Meanwhile, human organ generation pathological changes or exception, on its skin also there is obvious change in the current potential in corresponding acupuncture point or acupuncture point district.These features are confirmed by domestic and international a large amount of authoritative institutions institute.
In this utility model, make use of electric current from high potential to the feature of electronegative potential movement, the material of resistance characteristic is communicated with and human foci area, makes the potential difference of focal zone carry out electric current release until current potential progressively balances by resistance characteristic material.The balance of focal zone point-to-point transmission current potential, makes it series of biologic state response occurs, and by meridians indirect regulation body or organ dysfunction or state, reaches the object for the treatment of.
Utility model content
The purpose of this utility model is to provide a kind of without the need to power supply, by two conductive electrodes of same metal material characteristic (or different metal material characteristic), after carrying out reliable contacts with human foci area or the interregional skin every 2 of acupuncture point point, the inside and outside point-to-point transmission potential difference of human foci area's (or acupuncture point point) is made by the resistance characteristic material that two electrodes have connected, from high potential to electronegative potential release current, finally cause 2 current potentials by the balance that becomes.The mode of this balance focal zone (or acupuncture point point) current potential, indirectly can affect the subcutaneous sympathetic ganglion in focal zone, and make optimum current potential feature by meridians and sympathetic nerve knot, reflexively act on this regional organization or organ, finally reach disease treatment object New Type of Diseases cure mechanism.
Technical solution of the present utility model is: the treatment of release type potential balance is pasted, and comprises adhesive layer, it has two conductive electrodes at least, contact resistance elastomeric material layer between two conductive electrodes, forms current loop.The treatment of release type potential balance is pasted and is used for hypertension, heart disease, diabetes, cyclomastopathy, prostatosis, fatty liver or rheumatalgia auxiliary treatment.
Described conductive electrode can be the conductive electrode of two same material characteristics, as being both aluminum paper tinsel; Or the conductive electrode of two dissimilar material properties (active and torpescence), as an aluminium foil (active characteristic) and a native silver (torpescence characteristic).Torpescence conductive electrode can be metal species electrode, also can be the conductive electrode of non-metal kind, as conductive carbon fibre or electrically conductive graphite sheet.
Resistance characteristic material layer is by carbon fiber sheet or the resistive layer that is made up of aqueous gel.
The resistive layer moisture 45% of aqueous gel composition; Medical gel 25%; Medical non-woven dry goods or medical Zhan Lei basic unit 30%.
Two resistance between electrode are 100 Ω-10M Ω.Preferably two resistance between electrode are 510 Ω, 100 Ω.
In this utility model, with two (or more) conductive electrode, these two electric conductors (can be simple metal class, metallization dry goods, metallization stationery, metallized film class) conducting electricity very identical characteristics electric conductor or two different qualities (active characteristic, torpescence characteristic).Also can be the conductive electrode of non-metal kind, as carbon fiber, graphite flake etc.By the skin between inside and outside 2 of contact human foci area (or acupuncture point point), and form electric current Releasing loop with the resistance characteristic material be connected between two conductive electrodes, the last balance constantly regulating the inside and outside point-to-point transmission potential difference of human foci area's (or acupuncture point point), reaches the object of disease therapy.
This by discharging and balancing the mode of focal zone (or acupuncture point point) current potential, indirectly can affect the subcutaneous sympathetic ganglion in focal zone, and make optimum current potential feature by meridians and sympathetic nerve knot, reflexively act on this regional organization or organ, finally reach disease treatment object New Type of Diseases cure mechanism.
This cure mechanism, through clinical verification, to diseases such as hypertension, heart disease, diabetes, cyclomastopathy, prostatosis, fatty liver, rheumatisms, has obvious adjuvant treatment effect.
Application site:
Hypertension is attached to (umbilicus) place, SHENJUE acupoint position or tremulous pulse place, neck left and right.Heart disease is attached to place of heart district.Diabetes are attached to middle or Pancreatic Region in the middle part of back.Cyclomastopathy is attached to breast surface (avoiding the hypertrophy position of nipple).Prostatosis is attached to hypogastric region place (bladder location).Fatty liver is attached to hepatic region place.Arthralgia, rheumatalgia are attached to the position of pain.More than more than can pasting with subsides or one according to practical situation note.
On the note skin of using method 1(not allergic skin-directly): before use, wiped clean is waited to paste area skin, opens packaging, takes out treatment and pastes, and tears the protection sheet of two block protection paper above two electrodes and two electrode perimeter; Treatment is posted electrode surface and be directly posted on focal zone or disease corresponding acupuncture point point.
Using method 2(allergic skin-be attached to garment interior): open packaging, take out treatment and paste, tear the two block protection paper (protection sheet of two electrode perimeter does not tear) outside two electrode surfaces; Then after tearing whole protection sheet of electrodeless of another side, this face is attached to focal zone or garment interior corresponding to acupuncture point point, the corresponding skin at focal zone or acupuncture point point of electrode surface is posted in treatment.Pledge clothes human body skin time, treatment paste two electrodes namely can treat with contact human skin.
Using method 3(belt bundle method): before use, wiped clean is waited to paste area skin, opens packaging, takes out treatment and pastes; Tear the two block protection paper (protection sheet of two electrode perimeter does not tear) outside two electrode surfaces; Then after tearing whole protection sheet of electrodeless of another side, treatment pasted and be pasted onto Special waistband inboard and put the position that treatment pastes, the corresponding skin at focal zone or acupuncture point point of electrode surface is posted in treatment, has restrainted belt.Treatment subsides are now pressed in sufferer skin place by belt and treat.
Use suggestion: use first, suggestion using method 1 and 3(draw this two kinds of method best results).
The utility model has the advantages that: 1, structure simple, without the need to power supply, single use.2, volume frivolous (thickness < 1.5mm), do not affect wearing, cost is low, can significantly for user alleviates medical expense, easy to use, is convenient to accept.3, electrode and resistance characteristic material layer are food stage and environment-friendly materials, and conduction, nontoxic, skin are without anaphylaxis, and after single use, garbage is free from environmental pollution.4, make use of the resistance characteristic layer that non-toxic material is made cleverly, and by two conductive electrodes (same conductive or different conductive material properties), and after the skin between inside and outside 2 of human foci area's (or acupuncture point point) carries out reliable contacts, release is the inside and outside point-to-point transmission potential difference in balanced human focal zone (or acupuncture point point) also, carries out the mode of disease treatment.Paste use through Disease, property is pasted and can be taken effect after (or band with) 6-8 hour, continuous 3-7 days once a day, is weekly a course for the treatment of, usual 2-5 the course for the treatment of successful, be conducive to the auxiliary treatment of Disease.Through clinical verification to diseases such as hypertension, heart disease, diabetes, cyclomastopathy, prostatosis, fatty liver, rheumatalgia, there is obvious adjuvant treatment effect.
Below in conjunction with accompanying drawing, embodiment of the present utility model is described in further detail.
Accompanying drawing explanation
Fig. 1 is this utility model structure diagram.
Fig. 2 is this utility model second example structure sketch.
Fig. 3 is this utility model validation test method structure diagram.
Fig. 4 is Fig. 1 plan structure sketch.
Detailed description of the invention
See Fig. 1,2,3,4, parts title is as follows: conductive electrode 1,2, resistance characteristic material layer 3, adhesive layer 4, circuit tester 5, insulating barrier 7.
See Fig. 1,4, release type potential balance treatment subsides comprise adhesive layer 4, it have two conductive electrodes 1,2, be circular, have insulating barrier 7 between two conductive electrodes 1,2 at two conductive electrodes, 1,2 contact resistance elastomeric material layers, 3, two conductive electrode 1,2.Resistance characteristic material layer 3 is by carbon fiber sheet or the resistive layer that is made up of aqueous gel.The resistive layer moisture 45% of aqueous gel composition; Medical gel 25%; Medical non-woven dry goods or medical Zhan Lei basic unit 30%.Two resistance between electrode are 510 Ω or 100 Ω.
See Fig. 2, two conductive electrodes 1,2 are rectangle.Geometry is not limited thereto.
See Fig. 3, physical test method: test two conductive electrodes, 1,2 resistance with digital multimeter 5 ohms range.Test result is between 20 Ω-10M Ω (product classification difference is had any different).Demonstrate two conductive electrodes, 1,2 existence rationality resistance values.
Embodiment 1
The treatment of release type potential balance is attached to the application in the auxiliary treatment of the disease such as hypertension, heart disease, the conductive electrode (as aluminium foil and aluminium foil etc.) comprising two identical material characteristics is pasted in described treatment, at two conductive electrodes, 1,2 contact resistances (by carbon fiber or the resistive layer that is made up of aqueous gel), to form current flowing loop between two electrodes.Two resistance between electrode are 100 Ω or 500 Ω (two kinds of products).
Embodiment 2
The treatment of release type potential balance is attached in the auxiliary treatment of the disease such as hypertension, heart disease applies, the conductive electrode (as aluminium foil and copper pieces of cloth or silver-colored pieces of cloth) comprising two unlike material characteristics is pasted in described treatment, at two conductive electrodes, 1,2 contact resistances (by carbon fiber or the resistive layer that is made up of aqueous gel), to form current flowing loop between two electrodes.Two resistance between electrode are 100 Ω or 500 Ω (two kinds of products).
Resistance characteristic material layer used in above two embodiment, alternate material is:
1, carbon fiber electrically resistance layer: wherein carbon fiber is the thin slice of natural carbonaceous.2 or select aqueous gel resistive layer: wherein water 45%; Medical gel 25%; Medical non-woven dry goods or medical Zhan Lei basic unit 30%.Resistance characteristic material layer advantage is: conduction, nontoxic, skin are without anaphylaxis, and after once using, garbage is free from environmental pollution.
Experimental example 1
Clinical effect trial situation statistics is pasted in the treatment of release type potential balance:
1, case selection: hyperpietic 58 example, wherein male 40 example, women 18 example.
2, Therapeutic Method: be affixed on SHENQUE acupoint.Once-a-day, one time 8 hours 7 days is a course for the treatment of, treats 5 courses for the treatment of.
3, curative effect judging standard:
Efficacy evaluation is carried out with reference to efficacy of antihypertensive treatment evaluation criteria in " new Chinese medicine guideline of clinical investigations ".
Effective: diastolic pressure decline 1.3kpa, and reach normal range; Though diastolic pressure is not down to normally, decline 2.7kpa or following.Wherein one must be possessed.Blood pressure is basicly stable.
Effective: diastolic pressure declines not as good as 1.3kpa, but reaches normal range; Diastolic pressure comparatively treats the front 1.3-2.5kpa that declines, but does not reach normal range; Systolic pressure comparatively treats front more than decline 4.0kpa.Wherein one must be possessed.Clinical symptoms is obviously alleviated.
Invalid: not reach above standard person.Clinical symptoms is not improved.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Hypertension | 58 | 53 | 5 | 0 | 100 |
Clinical Practice proves: the auxiliary treatment being used for high blood pressure disease is pasted in the treatment of release type potential balance, and obvious effective rate 91.4%, effective percentage 8.6%, total effective rate is 100%.
Experimental example 2
Treatment diabetes clinical efficacy situation statistics is pasted in the treatment of release type potential balance:
1, case selection: diabetic patients person 67 example, wherein male 53 example, women 14 example, the age 40-65 year; Disease mostly is: polydipsia polyphagia, thirsty polyphagia, and polyuria is become thin, light red tongue.Blood glucose is higher than 11.1 mM/ls.When looking into fasting glucose, more than twice or twice higher than 7.8 mM/ls.
2, Therapeutic Method: paste middle or Pancreatic Region in the middle part of back.Once-a-day, one time 8 hours 7 days is a course for the treatment of, pastes with 5 courses for the treatment of.
3, curative effect judging standard:
Effective: after using Bioelectric patch, blood glucose and urine sugar value obviously reduce.
Effective: after using Bioelectric patch, blood glucose and glucose in urine all have reduction.
Invalid: after using Bioelectric patch, blood glucose and glucose in urine change little.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Diabetes | 67 | 54 | 13 | 0 | 100 |
Clinical Practice proves: the auxiliary treatment being used for diabetes is pasted in the treatment of release type potential balance, and obvious effective rate 80.6%, effective percentage 19.4%, total effective rate is 100%.
Experimental example 3
Treatment rheumatism clinical efficacy situation statistics is pasted in the treatment of release type potential balance:
1, case selection: rheumatisant 71 example, wherein male 60 example, women 11 example, the age 30-65 year.
2, Therapeutic Method: the position being attached to pain.Once-a-day, one time 8 hours 7 days is a course for the treatment of, treats 3 courses for the treatment of.
3, curative effect judging standard:
Effective: swollen, pain disappears, and joint, each position obviously improves.
Effective: swollen, pain obviously alleviates, joint, each position is seen and is made moderate progress.
Invalid: as before, joint, each position is with before treatment for swollen, pain.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Rheumatism | 71 | 52 | 19 | 0 | 100 |
Clinical Practice proves: the treatment of release type potential balance is pasted and is used for rheumatismal auxiliary treatment, and obvious effective rate 73.2%, effective percentage 26.8%, total effective rate is 100%.
Experimental example 4
Treatment cyclomastopathy clinical efficacy situation statistics is pasted in the treatment of release type potential balance:
1, case statistics: cyclomastopathy patient 41 example, the age, the course of disease was-4 years half a year in 31-50 one full year of life.
2, Therapeutic Method: release type potential balance treatment pressing is attached to patient's chest surface, and paste every day, often pasting use 6 hours, 7 days is a course for the treatment of.Treat 2 courses for the treatment of.
3, curative effect judging standard:
Effective: hypertrophy major part disappears, not pain, not distending pain.Mammary gland is firmly tough, the most of disappearance of thickened areas.
Effective: hypertrophy obviously disappears, pain, distending pain obviously alleviate.Mammary gland is firmly tough, thickened areas reduces, matter is soft.
Invalid: hypertrophy does not change or change not obvious, pain, distending pain do not alleviate or alleviate not obvious, without improving.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Cyclomastopathy | 41 | 30 | 11 | 0 | 100 |
Clinical Practice proves: release type potential balance treatment subsides have removes the effect such as mastalgia, softening hypertrophy.Obvious effective rate 73.2%, effective percentage 26.8%, total effective rate is 100%.
Experimental example 5
Treatment heart or angiopathy clinical efficacy situation statistics are pasted in the treatment of release type potential balance:
1, case statistics: heart or angiopathy case 45 example, the age, the course of disease was-6 years Mays in 40-55 one full year of life.
2, Therapeutic Method: release type potential balance treatment subsides are attached to position, patient's heart district, paste every day, often paste use 8 hours, 7 days be a course for the treatment of, treat 2 courses for the treatment of.
3, curative effect judging standard:
Effective: symptom and arrhythmia obviously alleviate, and the lab testings such as electrocardiogram obviously improve.
Effective: symptom alleviates or the intermittent time of showing effect extends, and lab testing is improved.
Invalid: symptom and arrhythmia unchanged.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Heart or angiopathy | 45 | 27 | 18 | 0 | 100 |
Clinical Practice proves: release type potential balance treatment subsides have the promotion rhythm of the heart and normally act on.Obvious effective rate 58%, effective percentage 42%, total effective rate is 100%.
Experimental example 6
Treatment prostatosis clinical efficacy situation statistics is pasted in the treatment of release type potential balance:
1, case statistics: prostate case 60 example, the age, the course of disease was-4 years half a year in 30-50 one full year of life.
2, Therapeutic Method: release type potential balance treatment subsides are attached to hypogastric region place, paste every day, often paste use 7 hours, 7 days be a course for the treatment of, treat 2 courses for the treatment of.
3, curative effect judging standard:
Effective: unobstructed micturition, prostatic examination is obviously reduced, and residual urine obviously reduces.
Effective: symptom of urinating takes a turn for the better, residual urine reduces.
Invalid: symptom and every inspection are all without improvement.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Prostate | 60 | 42 | 18 | 0 | 100 |
Clinical Practice proves: release type potential balance treatment subsides have to be beneficial to urinates, and reduces pain effect.Obvious effective rate 70%, effective percentage 30%, total effective rate is 100%.
Experimental example 7
Treatment fatty liver clinical efficacy situation statistics is pasted in the treatment of release type potential balance:
1, case selection: liver cirrhosis patient 38 example, wherein male 28 example, women 10 example, the age 27-45 year.
2, Therapeutic Method: release type potential balance treatment subsides are attached to position, hepatic region, and once-a-day, a time 7 hours 7 days is a course for the treatment of, treats 5 courses for the treatment of.
3, curative effect judging standard:
1, effective: the main clinic symptoms such as hepatic insufficiency, fatigue and weak such as patient's inappetence, lassitude and weak, Nausea and vomiting, hepatic region or upper right abdomen dull pain disappears, and muscle power is obviously recovered, liver function also be improved significantly.
2, effective: clinical symptom relief, liver function improves.
3, invalid: the symptom of patient, sign, liver function are all not improved.
4, therapeutic outcome:
| The state of an illness | Number | Effective | Effectively | Invalid | Total effective rate % |
| Fatty liver | 38 | 25 | 13 | 0 | 100 |
Clinical Practice proves: the auxiliary treatment to Patients with Fatty Liver is pasted in the treatment of release type potential balance, has obvious effect.Obvious effective rate 66%, effective percentage 34%, total effective rate is 100%.
Describe above, just detailed description of the invention of the present utility model, various illustrating is not construed as limiting flesh and blood of the present utility model.
Claims (7)
1. a release type potential balance treatment is pasted, it is characterized in that comprising adhesive layer (4), it have two conductive electrodes (1), (2) at least, contact resistance elastomeric material layer (3) between two conductive electrodes (1), (2).
2. paste according to release type potential balance according to claim 1 treatment, it is characterized in that two conductive electrodes (1), (2) be the electric conductor of two same material characteristic conductance bodies or two dissimilar material properties.
3. paste according to release type potential balance according to claim 1 treatment, it is characterized in that two conductive electrodes (1), (2) be the conductive electrode of non-metal kind, specifically carbon fiber or graphite flake.
4. paste according to release type potential balance according to claim 1 treatment, it is characterized in that resistance characteristic material layer (3) is by carbon fiber sheet or the resistive layer that is made up of aqueous gel.
5. paste according to release type potential balance treatment according to claim 1, it is characterized in that the resistive layer moisture 45% that aqueous gel forms; Medical gel 25%; Medical non-woven dry goods or medical Zhan Lei basic unit 30%.
6. paste according to release type potential balance treatment according to claim 1, it is characterized in that two resistance between electrode elastomeric material layer (3) resistance are 100 Ω or 500 Ω.
7. paste according to release type potential balance treatment according to claim 1, it is characterized in that for hypertension, heart disease, diabetes, cyclomastopathy, prostatosis, fatty liver or rheumatalgia auxiliary treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520234215.XU CN204563307U (en) | 2015-04-19 | 2015-04-19 | The treatment of release type potential balance is pasted |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520234215.XU CN204563307U (en) | 2015-04-19 | 2015-04-19 | The treatment of release type potential balance is pasted |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204563307U true CN204563307U (en) | 2015-08-19 |
Family
ID=53856004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201520234215.XU Expired - Fee Related CN204563307U (en) | 2015-04-19 | 2015-04-19 | The treatment of release type potential balance is pasted |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204563307U (en) |
-
2015
- 2015-04-19 CN CN201520234215.XU patent/CN204563307U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106821706A (en) | A kind of brassiere for preventing and treating mammary gland disease | |
| CN104759026A (en) | Release type electric potential balance treatment patch | |
| CN204563307U (en) | The treatment of release type potential balance is pasted | |
| CN204563308U (en) | Physical and chemical reaction DC treatment pastes | |
| CN102988900B (en) | Traditional Chinese medicine enema used for treating senile functional constipation | |
| CN205125241U (en) | Magnetic therapy insole | |
| CN202761913U (en) | Human body external control channels and collaterals biological electro-therapeutic apparatus | |
| CN205924709U (en) | Frequency conversion biological electricity pulse diabetes physiotherapy equipment | |
| CN104225783B (en) | Bio-electrical paste for hyperplasia of mammary glands, breast nodule and lumbar disc herniation | |
| CN208741261U (en) | A kind of TCM Gynecology hot application device | |
| CN201806827U (en) | Electric heating physiotherapy health-care belt | |
| CN204379531U (en) | Solar energy gynecologic menstrual heating cushion | |
| CN203400240U (en) | Thermal insulation foot-warming boot | |
| CN201830905U (en) | Healthcare underpants for men | |
| CN205547583U (en) | Health care shoe -pad | |
| CN110251833A (en) | A kind of pressure trousers with massage functions | |
| CN208598621U (en) | A kind of adjuvant treatment socks of ICU patient | |
| CN104784817A (en) | Physical-chemical reaction direct-current treatment patch | |
| CN213785390U (en) | Underpants with EMS micro-current | |
| CN204763440U (en) | Healthy physiotherapy pants of nanometer far infrared prostate | |
| CN201469904U (en) | Electric acupoint physiotherapy device | |
| CN202568833U (en) | Health-care glove | |
| CN206534140U (en) | A kind of Multifunctional bra | |
| CN2759502Y (en) | Hands and feed membranous electrode | |
| CN203458689U (en) | Blood pressure balancing instrument |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150819 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |